DRAP Recommends to Reduce the Price of Remdesivir Injection by 38%

DRAP

Earlier today, the Drug Regulatory Authority of Pakistan (DRAP) recommended a reduction in the price of Remdesivir injection price by up to 38% and suggested to set the price at Rs.5, 680.

According to the details, the health ministry sent a summary to the federal cabinet after which the federal government decided to approve the reduction in the rates of the injection used for the treatment of the novel coronavirus pandemic.

The summary to make a cut in the price of Remdesivir injection to Rs.3, 564 will most likely be approved by the Federal cabinet.

DRAP’s summary suggested setting the price at up to Rs.5, 680 for 100mg Remdesivir injection after noticing a major decline in its prices globally. Previously on the 16th of June, the federal cabinet fixed the price of the injection at Rs.10, 873.

The Drug Regulatory Authority Pakistan released a summary on November 9th according to which, the authority reduced the rates of the injection on 17th August from Rs.10, 873 to up to Rs.9, 224. Now, the price of the Remdesivir injection used for the treatment of COVID-19 has observed a fall in its price globally from $50 to $35.

A federal cabinet session was held earlier today led by PM Khan in which he discussed a 14-point agenda including considering to reduce the price of the injection and also revised the notification about the prices of medicines.

More read: First House Constructed Under Naya Pakistan Housing Scheme In Islamabad

Leave a Reply

Your email address will not be published. Required fields are marked *